These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17308047)

  • 1. R16, a novel amonafide analogue, induces apoptosis and G2-M arrest via poisoning topoisomerase II.
    Zhu H; Huang M; Yang F; Chen Y; Miao ZH; Qian XH; Xu YF; Qin YX; Luo HB; Shen X; Geng MY; Cai YJ; Ding J
    Mol Cancer Ther; 2007 Feb; 6(2):484-95. PubMed ID: 17308047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naphthalimides induce G(2) arrest through the ATM-activated Chk2-executed pathway in HCT116 cells.
    Zhu H; Miao ZH; Huang M; Feng JM; Zhang ZX; Lu JJ; Cai YJ; Tong LJ; Xu YF; Qian XH; Ding J
    Neoplasia; 2009 Nov; 11(11):1226-34. PubMed ID: 19881958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amonafide, a topoisomerase II inhibitor, is unaffected by P-glycoprotein-mediated efflux.
    Chau M; Christensen JL; Ajami AM; Capizzi RL
    Leuk Res; 2008 Mar; 32(3):465-73. PubMed ID: 17826829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MFTZ-1, an actinomycetes subspecies derived antitumor macrolide, functions as a novel topoisomerase II poison.
    Xie CY; Zhu H; Lin LP; Miao ZH; Geng MY; Cai YJ; Chen Y; Zhao HJ; Luo HB; Zhang XW; Fan LM; Shen YM; Ding J
    Mol Cancer Ther; 2007 Nov; 6(11):3059-70. PubMed ID: 18025289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer Activity and Topoisomerase II Inhibition of Naphthalimides with ω-Hydroxylalkylamine Side-Chains of Different Lengths.
    Tomczyk MD; Byczek-Wyrostek A; Strama K; Wawszków M; Kasprzycki P; Walczak KZ
    Med Chem; 2019; 15(5):550-560. PubMed ID: 30207241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome-dependent degradation of Chk1 kinase induced by the topoisomerase II inhibitor R16 contributes to its anticancer activity.
    Feng JM; Zhu H; Zhang XW; Ding J; Miao ZH
    Cancer Biol Ther; 2008 Nov; 7(11):1726-31. PubMed ID: 18787399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M(2)-A induces apoptosis and G(2)-M arrest via inhibiting PI3K/Akt pathway in HL60 cells.
    Wang J; Wu A; Xu Y; Liu J; Qian X
    Cancer Lett; 2009 Oct; 283(2):193-202. PubMed ID: 19435648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethonafide-induced cytotoxicity is mediated by topoisomerase II inhibition in prostate cancer cells.
    Pourpak A; Landowski TH; Dorr RT
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1109-17. PubMed ID: 17351106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cysteine-reactive alkyl hydroquinone modifies topoisomerase IIα, enhances DNA breakage, and induces apoptosis in cancer cells.
    Lin TY; Huang CP; Au LC; Chang YW; Hu CY; Lin SB
    Chem Res Toxicol; 2012 Nov; 25(11):2340-51. PubMed ID: 23088786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riccardin D, a novel macrocyclic bisbibenzyl, induces apoptosis of human leukemia cells by targeting DNA topoisomerase II.
    Xue X; Qu XJ; Gao ZH; Sun CC; Liu HP; Zhao CR; Cheng YN; Lou HX
    Invest New Drugs; 2012 Feb; 30(1):212-22. PubMed ID: 20924640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage.
    Gieseler F; Bauer E; Nuessler V; Clark M; Valsamas S
    Leukemia; 1999 Nov; 13(11):1859-63. PubMed ID: 10557063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anticancer activities of 6-amino amonafide derivatives.
    Norton JT; Witschi MA; Luong L; Kawamura A; Ghosh S; Stack MS; Sim E; Avram MJ; Appella DH; Huang S
    Anticancer Drugs; 2008 Jan; 19(1):23-36. PubMed ID: 18043127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain.
    Qin Y; Meng L; Hu C; Duan W; Zuo Z; Lin L; Zhang X; Ding J
    Mol Cancer Ther; 2007 Sep; 6(9):2429-40. PubMed ID: 17876042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Base sequence determinants of amonafide stimulation of topoisomerase II DNA cleavage.
    De Isabella P; Zunino F; Capranico G
    Nucleic Acids Res; 1995 Jan; 23(2):223-9. PubMed ID: 7862525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naphthalimides exhibit in vitro antiproliferative and antiangiogenic activities by inhibiting both topoisomerase II (topo II) and receptor tyrosine kinases (RTKs).
    Wang X; Chen Z; Tong L; Tan S; Zhou W; Peng T; Han K; Ding J; Xie H; Xu Y
    Eur J Med Chem; 2013 Jul; 65():477-86. PubMed ID: 23770449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of topoisomerase IIα and induction of DNA damage in cholangiocarcinoma cells by altholactone and its halogenated benzoate derivatives.
    Kitdumrongthum S; Reabroi S; Suksen K; Tuchinda P; Munyoo B; Mahalapbutr P; Rungrotmongkol T; Ounjai P; Chairoungdua A
    Biomed Pharmacother; 2020 Jul; 127():110149. PubMed ID: 32344256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes.
    Meng LH; Zhang JS; Ding J
    Biochem Pharmacol; 2001 Sep; 62(6):733-41. PubMed ID: 11551518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5k, a novel β-O-demethyl-epipodophyllotoxin analogue, inhibits the proliferation of cancer cells in vitro and in vivo via the induction of G2 arrest and apoptosis.
    Xu D; Cao J; Qian S; Li L; Hu C; Weng Q; Lou J; Zhu D; Zhu H; Hu Y; He Q; Yang B
    Invest New Drugs; 2011 Oct; 29(5):786-99. PubMed ID: 20352292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
    Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
    J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
    Morgan SE; Cadena RS; Raimondi SC; Beck WT
    Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.